1 / 16

The Three Phases of Collaboration: Chronic Disease Management, Cancer Prevention, and Capacity

The Three Phases of Collaboration: Chronic Disease Management, Cancer Prevention, and Capacity. Kim Salamone , Ph.D. Vice President, Health Information Technology. Health Services Advisory Group. Quality Improvement Organization for Arizona, California, and Florida

paul
Download Presentation

The Three Phases of Collaboration: Chronic Disease Management, Cancer Prevention, and Capacity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Three Phases of Collaboration: Chronic Disease Management, Cancer Prevention, and Capacity Kim Salamone, Ph.D. Vice President, Health Information Technology

  2. Health Services Advisory Group • Quality Improvement Organization for Arizona, California, and Florida • Subrecipient for Arizona Regional Extension Center (REC) • Dedicated to improving quality of care delivery and health outcomes through information, education, and assistance • Partners with physicians, health plans, nursing homes, hospitals

  3. Agenda • Overview of 3 Phases • Goals • Outcomes • Lessons Learned • Barriers to reporting • Motivation to overcome barriers

  4. National Strategy for Quality Improvement in Healthcare

  5. Phase 1: Chronic Disease Management • Use Electronic Health Records (EHRs) to manage patients with chronic diseases => increased quality of healthcare • Baseline of Stage 1 core meaningful use (MU) and core clinical quality measures (CQMs) • Mammography screening, colorectal cancer screening, cervical cancer screening, and chlamydia screening • Administered the ASHLine Tobacco Cessation Assessment Tool to each site

  6. Phase 1 Outcomes • No CHCs had actually reached MU. • Medicaid Adopt/Implement/Update (AIU) • Out of the 8 community health centers (CHCs) that purchased NextGen, only Chiricauhua and Adelantehad received the necessary health quality measures (HQM) module. • The HQM was proven problematic • Some interfaces didn’t work • Calculations were wrong on CQMs

  7. Phase 1: Lessons Learned • Thresholds were difficult to meet for MU: • Clinical summaries • Providing patients with an electronic copy of their health information (including diagnostic test results, problem lists, medication lists, medication allergies) upon request • Reminders to patients, per patient preference, for preventive/follow up care • Diabetes measures were difficult to calculate for NextGen users. • Users struggled with documentation.

  8. Phase 2: Cancer Screening Measures • Limited budget and scope • AdelenteHealthcare • Mountain Park • Maricopa County Health Care for the Homeless (MCHCH) • Wesley • Providers had met Stage 1, year 1 MU • Adelente could not produce the CQMs • MCHCH was the only one where baseline measures were generated for diabetes measures • Every CHC improved • Breast cancer screening • Diabetes LDL management control • Diabetes A1C control

  9. Phase 2: Lessons Learned • Healthcare reform requires implementing change systemically • Using an EHR in a meaningful way • Improving quality measures • Implementing quality improvement projects • Emphasizing preventive medicine • Barriers that remain: • Data entry of labs, cancer screening reports, and other scanned-in reports • Changes in EHRs • Users still struggle with documentation

  10. Phase 3: Capacity Building • EHRs • 2 Next Gens • 1 eCW • Aligned with Arizona Department of Health Services (ADHS) and Centers for Disease Control and Prevention (CDC) measure interests • Five distinct elements • Assessment • Baseline determinations • Workflow review • Capacity development • Identify best practices

  11. Phase 3: Assessment • Current utilization of the EHR to maintain current and complete information related to multiple measures • MU-focused • Measure specifications different • 90 days • EHRs restricted outside of MU requirements • Issue with 2014 versions

  12. Phase 3: Capacity Building • Currently generating measures: • Current baseline screening rates for breast, cervical and colorectal cancers • Percent of the diabetes population within range for HbA1C • Percent of population with smoking assessed, and a referral to ASHlinerecorded for smokers • Percent of population with BMI assessed and recorded • Percent of population with complete HPV immunizations • Percent of population with alcohol use assessed • Percent of population with physical activity assessed, addressed

  13. Phase 3: Current Status and Next Steps • Current Status • Have baseline measures for Adelente • Feedback reports generated for each site • Started workflow analyses at each site • Next Steps • Obtain baseline from the other 2 CHCs • Produce feedback reports and conduct workflow analyses • Capacity development • Train the trainer on generating care management reports • Implement preventive, patient-centered procedures • Share best practices with ADHS, Arizona Alliance for Community Health Centers (AACHC), and others for dissemination

  14. Barriers to Reporting • Physician buy-in • Takes away from direct patient care • Adds work time • Less efficient than paper • EHRs • Some have multiple ways to input the same measure, example: BP • Confusion regarding requirements • Standards • Interoperability

  15. Motivating providers • Must align with National Strategy • Must demonstrate level of care • Must demonstrate quality of care • The U. S. Department of Health and Human Services (HHS) beginning to align measures and payment mechanisms • MU • PCMH • ACA • PQRS

  16. Additional Questions? Kim Harris-Salamone, PhD, MPA Vice President, Health Information Technology Health Services Advisory Group KSalamone@hsag.com

More Related